Effect of Menopause on the Increased Cardiovascular Risk Factors at Public Health Centers in Semarang Regency

https://doi.org/10.22146/jkr.107527

Dedi Haswan(1*), Indah Kurniawati(2), Jatmiko Susilo†(3)

(1) Program Studi Farmasi Fakultas Kesehatan, Universitas Ngudi Waluyo. Jl. Diponegoro 186 Ungaran, Kabupaten Semarang. 5-512. Telp. (024)
(2) Program Studi Farmasi Fakultas Kesehatan, Universitas Ngudi Waluyo. Jl. Diponegoro 186 Ungaran, Kabupaten Semarang. 5-512. Telp. (024)
(3) Program Studi Farmasi Fakultas Kesehatan, Universitas Ngudi Waluyo. Jl. Diponegoro 186 Ungaran, Kabupaten Semarang. 5-512. Telp. (024), penulis telah meninggal dunia tanggal 11/8/2025
(*) Corresponding Author

Abstract


Background: Menopause potentially causes changes in metabolic disorders and atherosclerosis. This condition triggers cardiovascular disease (CVD) 16 times greater than breast cancer.

Objective: This study aimed to identify the prevalence of CVD risk factors in Prolanis participants at the Semarang Regency Health Center.

Methods: A cross-sectional study was conducted with 147 participants, who were selected from a group of 208 individuals who had undergone menopause and agreed to participate, and for whom complete data was available. Data on body mass index, blood pressure, random glucose levels, and cholesterol were collected from August to October 2025. Statistical analyses were then performed using one-way ANOVA and Pearson's correlation test.

Results: The results showed that menopause and the age at first menopause were significantly different, while the differences and correlations between menopause and blood pressure, blood glucose, and lipid levels were not significant.

Conclusion: The prevalence of metabolic syndrome (Met-S) in postmenopausal women increases with age. Menopause and Met-S had no significant differences and correlations, although women with Met-S showed a higher risk of CVD.


Keywords


Cardiovascular, menopause, metabolic syndrome, risk factors

Full Text:

PDF


References

  1. Harmadha, W. S. P., Muharram, F. R., Gaspar, R. S., Azimuth, Z., Sulistya, H. A., Firmansyah, F. et al. Explaining the increase of incidence and mortality from cardiovascular disease in Indonesia: A global burden of disease study analysis (2000-2019). PloS one, 18(12), e0294128 https://doi.org/101371/journal.pone0294128. 2023;
  2. Muharram FR, Multazam CECZ, Mustofa A, Socha W, Andrianto null, Martini S, et al. The 30 Years of Shifting in The Indonesian Cardiovascular Burden-Analysis of The Global Burden of Disease Study. J Epidemiol Glob Health. 2024 Mar;14(1):193–212.
  3. Muharram, F.R., Multazam, C.E.C.Z., Mustofa, A. Socha, W. Andrianto, Martini S et al. The 30 Years of Shifting in The Indonesian Cardiovascular Burden—Analysis of The Global Burden of Disease Study. J Epidemiol Glob Health 14, 193–212. 2024;
  4. Mounier-Vehier C. Women’s cardiovascular risk before and after menopause: A red alert for heart attack!. Annales d’endocrinologie, 82(3-4), 134. 2021;
  5. Wang, Q., Ferreira, D. L. S., Nelson, S. M., Sattar, N., Ala-Korpela, M., & Lawlor DA. Metabolic characterization of menopause: cross-sectional and longitudinal evidence. BMC medicine, 16(1), 17. 2018;
  6. Chen, Y., Wang, A., Zhang, X., Xia, F., & Zhao X. Effect of age at menopause and menopause itself on high sensitivity C-reactive protein, pulse wave velocity, and carotid intima-media thickness in a Chinese population. Medicine, 102(42), e35629. 2023;
  7. Kamińska, M. S., Schneider-Matyka, D., Rachubińska, K., Panczyk, M., Grochans, E., & Cybulska AM. Menopause Predisposes Women to Increased Risk of Cardiovascular Disease. Journal of clinical medicine, 12(22), 7058. 2023;
  8. Koothirezhi, R., & Ranganathan S. Postmenopausal Syndrome. In StatPearls. StatPearls Publishing. 2023.
  9. TRUE Consortium. Recommended Standards for Assessing Blood Pressure in Human Research Where Blood Pressure or Hypertension Is a Major Focus. Kidney international reports, 2(4), 733–738. 2017;
  10. WHO. WHO Waist Circumference and Waist-Hip Ratio Report of a WHO Expert Consultation. Available online: https://www.who.int/nutrition/publications/obesity/WHO_report_waistcircumference_and_waisthip_ratio/en/. 2022.
  11. Swarup S, Ahmed I, Grigorova Y, & Zeltser R. Metabolic Syndrome. [Updated 2024 Mar 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459248/. 2024.
  12. Vizmanos, B., Betancourt-Nuñez, A., Márquez-Sandoval, F., González-Zapata, L. I., Monsalve-Álvarez, J., Bressan, J. et al. Metabolic Syndrome Among Young Health Professionals in the Multicenter Latin America Metabolic Syndrome Study. Metabolic syndrome and related disorders, 18(2), 86–95. 2020;
  13. Gaita, L., Timar, B., Timar, R., Fras, Z., Gaita, D., & Banach M (2024). Lipid Disorders Management Strategies in Prediabetic and Diabetic Patients. Pharmaceuticals (Basel, Switzerland), 17(2), 219. 2024;
  14. Colpani, V., Baena, C. P., Jaspers, L., van Dijk, G. M., Farajzadegan, Z., Dhana, K., et al. Lifestyle factors, cardiovascular disease and all-cause mortality in middle-aged and elderly women: a systematic review and meta-analysis. European journal of epidemiology, 33(9), 831–845. 2018;
  15. McCarthy, M., & Raval AP. The peri-menopause in a woman’s life: a systemic inflammatory phase that enables later neurodegenerative disease. Journal of neuroinflammation, 17(1), 317. 2020;
  16. Chavda, V. P., Feehan, J., & Apostolopoulos V. Inflammation: The Cause of All Diseases. Cells, 13(22), 1906 https://doi.org/103390/cells13221906. 2024;
  17. Liu, C., Li, Y., Li, J., Jin, C., & Zhong D. The Effect of Psychological Burden on Dyslipidemia Moderated by Greenness: A Nationwide Study from China. Int J Environ Res Public Health, 19(21), 14287 https://doi.org/103390/ijerph192114287. 2022;
  18. Huan, L., Deng, X., He, M., Chen, S., & Niu W. Meta-analysis: Early Age at Natural Menopause and Risk for All-Cause and Cardiovascular Mortality. BioMed research international,, 6636856. 2021;
  19. Sayed A. I. Gender Differences in Coronary Artery Disease, Clinical Characteristics, and Angiographic Features in the Jazan Region, Saudi Arabia. Cureus, 14(10), e30239. 2022;
  20. Zhu, D., Chung, H. F., Dobson, A. J., Pandeya, N., Giles, G. G., Bruinsma, F. et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. The Lancet Public health, 4(11), e553–e564. 2019;
  21. Stevenson, J. C., Collins, P., Hamoda, H., Lambrinoudaki, I., Maas, A. H. E. M., Maclaran, K. et al. Cardiometabolic health in premature ovarian insufficiency. Climacteric : the journal of the International Menopause Society, 24(5), 474–480. 2021;
  22. Roa-Díaz, Z. M., Raguindin, P. F., Bano, A., Laine, J. E., Muka, T., & Glisic M. Menopause and cardiometabolic diseases: What we (don’t) know and why it matters. Maturitas, 152, 48–56. 2021;
  23. Choi, H. R., Chang, Y., Kim, Y., Cho, Y., Kwon, M. J., Kang et al. Vasomotor and other menopause symptoms and the prevalence of ideal cardiovascular health metrics among premenopausal stage women. Menopause (New York, NY), 30(7), 750–757 https://doi.org/101097/GME0000000000002203. 2023;
  24. Thurston R. C. Vasomotor symptoms and cardiovascular health: findings from the SWAN and the MsHeart/MsBrain studies. Climacteric : the journal of the International Menopause Society, 27(1), 75–80. 2024;
  25. Armeni, A., Anagnostis, P., Armeni, E., Mili, N., Goulis, D., & Lambrinoudaki I. Vasomotor symptoms and risk of cardiovascular disease in peri- and postmenopausal women: A systematic review and meta-analysis. Maturitas, 171, 13–20. 2023;
  26. Jamali, Z., Khalili, P., Ayoobi, F., Vatankhah, H., Esmaeili-Nadimi, A., Ranjbar, F. E. et al. Type of menopause, age of menopause and cardiovascular disease: a cross-sectional study based on data from Rafsanjan cohort study. BMC women’s health, 24(1), 626 https://doi.org/101186/s12905-024-03452-x. 2024;
  27. Anagnostis, P., Lambrinoudaki, I., Stevenson, J. C., & Goulis DG. Menopause-associated risk of cardiovascular disease. Endocrine connections, 11(4), e210537. 2022;
  28. Vervoort, D., Wang, R., Li, G., Filbey, L., Maduka, O., Brewer, L. C. et al. Addressing the Global Burden of Cardiovascular Disease in Women: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 83(25), 2690–2707 https://doi.org/101016/j.jacc202404028. 2024;
  29. Rifin, H. M., Omar, M. A., Wan, K. S., & Rodzlan Hasani WS. 10-year risk for cardiovascular diseases according to the WHO prediction chart: findings from the National Health and Morbidity Survey (NHMS) 2019. BMC public health, 24(1), 2513 https://doi.org/101186/s12889-024-19993-7. 2024;
  30. Choi, H. R., Chang, Y., Kim, Y., Cho, Y., Kwon, M. J., Kang, J., et al. Vasomotor and other menopause symptoms and the prevalence of ideal cardiovascular health metrics among premenopausal stage women. Menopause (New York, NY), 30(7), 750–757. 2023;
  31. Huang, C. H., Kor, C. T., Lian, I. B., & Chang CC. Menopausal symptoms and risk of heart failure: a retrospective analysis from Taiwan National Health Insurance Database. ESC heart failure, 8(4), 3295–3307 https://doi.org/101002/ehf213480. 2021;
  32. Manrique-Acevedo, C., Chinnakotla, B., Padilla, J., Martinez-Lemus, L. A., & Gozal D. Obesity and cardiovascular disease in women. International journal of obesity (2005), 44(6), 1210–1226. 2020;
  33. Prabakaran, S., Schwartz, A., & Lundberg G. Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use. Therapeutic advances in endocrinology and metabolism, 12, 20420188211013917. 2021;
  34. Borén, J., Öörni, K., & Catapano AL. The link between diabetes and cardiovascular disease. Atherosclerosis, 394, 117607. 2024;
  35. Kim E, Lee Y & KHC. Association between reproductive aging and hypertension among Korean women. Cardiovasc Prev Pharmacother ;4(1):34-41. 2022;
  36. Okeahialam, B. N., Agbo, H., Chuhwak, E., & Isiguzoro I. Arterial hypertension in women: Menopause as a risk window. Post reproductive health, 28(1), 19–22. 2022;
  37. Kamińska, M. S., Schneider-Matyka, D., Rachubińska, K., Panczyk, M., Grochans, E., & Cybulska AM. Menopause Predisposes Women to Increased Risk of Cardiovascular Disease. Journal of Clinical Medicine, 12(22), 7058. 2023;
  38. Li, S., Tan, I., Atkins, E., Schutte, A. E., & Gnanenthiran SR. The Pathophysiology, Prognosis and Treatment of Hypertension in Females from Pregnancy to Post-menopause: A Review. Current heart failure reports, 21(4), 322–336. 2024;
  39. Lambrinoudaki, I., Paschou, S. A., Armeni, E., & Goulis DG. The interplay between diabetes mellitus and menopause: clinical implications. Nature reviews. Endocrinology, 18(10), 608–622. 2022;
  40. Wojtacha, J. J., Morawin, B., Wawrzyniak-Gramacka, E., Tylutka, A., Freitas, A. K. E., & Zembron-Lacny A. Endothelial Dysfunction with Aging: Does Sex Matter?. International journal of molecular sciences, 25(22), 12203 https://doi.org/103390/ijms252212203. 2024;
  41. Nwia, S. M., Leite, A. P. O., Li, X. C., & Zhuo JL. Sex differences in the renin-angiotensin-aldosterone system and its roles in hypertension, cardiovascular, and kidney diseases. Frontiers in cardiovascular medicine, 10, 1198090. 2023;
  42. Barris CT FJL& de CE. Salt Sensitivity of Blood Pressure in Women,. AHA/ASA Journal, Hypertension, 80 (2), 268-278. 2022;
  43. Buleishvili M, Lobjanidze N, Ormotsadze G, Enukidze M, Machavariani M, Sanikidze T. ESTROGEN RELATED MECHANISMS OF HYPERTENSION IN MENOPAUSAL WOMEN. Georgian Med News. 2016 June;(255):45–51.
  44. Sabbatini, A. R., & Kararigas G. Estrogen-related mechanisms in sex differences of hypertension and target organ damage. Biology of sex differences, 11(1), 31. 2020;
  45. Yusuf, S., Joseph, P., Rangarajan, S., Islam, S., Mente, A., Hystad, P. et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet (London, England), 395(10226), 795–808. 2020;
  46. Fuchs, F. D., & Whelton PK. High Blood Pressure and Cardiovascular Disease. Hypertension (Dallas, Tex: 1979), 75(2), 285–292. 2020;
  47. Zakerinasab, F., Saraireh, T. H. A., Amirbeik, A., Zadeh, R. H., Mojeni, F. A., & Behfar Q. Association of age at menopause with type 2 diabetes mellitus in postmenopausal women: a systematic review and meta-analysis. Przeglad menopauzalny = Menopause review, 23(4), 207–215. 2024;
  48. Bazmandegan, G., Abbasifard, M., Nadimi, A. E., Alinejad, H., & Kamiab Z. Cardiovascular risk factors in diabetic patients with and without metabolic syndrome: a study based on the Rafsanjan cohort study. Scientific reports, 13(1), 559 https://doi.org/101038/s41598-022-27208-5. 2023;
  49. Purohit, A., Kim, Y. J., & Michos ED. Cardiovascular disease prevention in women - the current state in 2023. Current opinion in cardiology, 39(1), 54–60 https://doi.org/101097/HCO0000000000001099. 2024;
  50. Santos, M. P., Li, Y., Bazzano, L. A., He, J., Rexrode, K. M., & Ley SH. Age at menarche, type 2 diabetes and cardiovascular disease complications in US women aged under 65 years: NHANES 1999-2018. BMJ nutrition, prevention & health, 6(2), 293–300 https://doi.org/101136/bmjnph-2023-000632. 2023;
  51. Ntikoudi, A., Spyrou, A., Evangelou, E., Dokoutsidou, E., & Mastorakos G. The Effect of Menopausal Status, Insulin Resistance and Body Mass Index on the Prevalence of Non-Alcoholic Fatty Liver Disease. witzerland), 12(11), 1081. 2024;
  52. Westcott, F., Dearlove, D. J., & Hodson L. Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk. Atherosclerosis, 394, 117237. 2024;
  53. Luciani, L. Pedrelli, M. & Parini P. Modification of lipoprotein metabolism and function driving atherogenesis in diabetes,. Atherosclerosis; 394, 117545. 2024;
  54. Wooten, J. S., Webb, B. L., DiMarco, N. M., Nichols, D. L., & Sanborn CF. Impact of Menopause and Body Composition Status on Dyslipidemia in Women. A. American journal of health behavior, 45(1), 71–80. 2021;
  55. Ottarsdottir, K., Tivesten, Å., Ohlsson, C., Li, Y., Hellgren, M., Lindblad, U. et al. Endogenous sex hormone levels are associated with the revised Framingham Stroke Risk Profile in postmenopausal women: a longitudinal study in a Swedish cohort. BMC endocrine disorders, 25(1), 24 https://doi.org/101186/s12902-025-01841-3. 2025;
  56. Gaggini, M., Gorini, F., & Vassalle C. Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia. International journal of molecular sciences, 24(1), 75. 2022;
  57. Yoon, C. W., & Bushnell CD. Stroke in Women: A Review Focused on Epidemiology, Risk Factors, and Outcomes. Journal of stroke, 25(1), 2–15. 2023;
  58. Faltas, C. L., LeBron, K. A., & Holz MK. Unconventional Estrogen Signaling in Health and Disease. Endocrinology, 161(4), bqaa030. 2020;



DOI: https://doi.org/10.22146/jkr.107527

Article Metrics

Abstract views : 129 | views : 55

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Jurnal Kesehatan Reproduksi Indexed by:

 

 



SEKRETARIAT JURNAL KESEHATAN REPRODUKSI
Departemen Obstetri dan Ginekologi, FK-KMK, UGM/RS Dr. Sardjito
Jl. Kesehatan No. 1, Sekip Utara, Yogyakarta 55281
Email: jurnal.kesehatanreproduksi@ugm.ac.id
Cp: Admin Jurnal +6282146143990